Pharmacogenetic testing among patients with depression in a US managed care population

Actionable drug–gene pairs relevant to depression treatment include CYP2D6 and CYP2C19 with specific antidepressants. While clinical use of pharmacogenetic testing is growing, little is known about pharmacogenetic testing for depression treatment in managed care. We determined the incidence of singl...

Descripción completa

Detalles Bibliográficos
Autores principales: Anderson, Heather D., Thant, Thida M., Kao, David P., Crooks, Kristy R., Mendola, Nicholas D., Aquilante, Christina L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283740/
https://www.ncbi.nlm.nih.gov/pubmed/35385214
http://dx.doi.org/10.1111/cts.13279

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283740/
https://www.ncbi.nlm.nih.gov/pubmed/35385214
http://dx.doi.org/10.1111/cts.13279

Ejemplares similares